FIELD: pharmacy.
SUBSTANCE: invention relates to new compounds of formula I 
.
EFFECT: new compound of formula I are obtained, their application for metabolic syndrome, metabolic disease or metabolic disorders treatment is proposed.
16 cl, 8 tbl, 37 ex, 8 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION POSSESSING ANTIDIABETIC, HYPOLIPIDEMIC, HYPOGLYCEMIC AND CHOLESTEROL LOWERING ACTION, WAY OF ITS RECEPTION AND WAYS OF TREATMENT OF SPECIFIED DISEASES | 2007 |
|
RU2361581C2 |
| AMINOGUANIDINE CARBOXYLATES | 1995 |
|
RU2162462C2 |
| COMPOSITIONS COMPRISING ENZYME-CLEAVABLE KETONE-MODIFIED OPIOID PRODRUGS AND OPTIONAL INHIBITORS THEREOF | 2010 |
|
RU2600736C2 |
| HETEROCYCLIC COMPOUNDS OF BENZODIOXOL OR BENZODIOXEPIN AS INHIBITORS OF PHOSPHODIESTERASES | 2011 |
|
RU2583787C2 |
| DERIVATIVES OF 1,2,4-TRIAZOLE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2003 |
|
RU2319703C2 |
| FAMILY OF ARYL, HETEROARYL, O-ARYL AND O-HETEROARYL CARBASUGARS | 2012 |
|
RU2603769C2 |
| NEW HETEROCYCLIC FLUORGLUCOSIDE DERIVATIVES, MEDICATIONS CONTAINING THESE COMPOUNDS, AND THEIR APPLICATION | 2003 |
|
RU2339641C2 |
| PHARMACEUTICAL COMBINATION CONTAINING SGLT2 INHIBITOR | 2008 |
|
RU2489151C2 |
| NEW ANTIMICROBIAL COMPOUNDS, THEIR USE FOR TREATMENT OF MAMMALIAN INFECTIONS AND NEW METABOLIC MECHANISM | 2017 |
|
RU2752568C2 |
| NOVEL AROMATIC FLUOROGLYCOSIDE DERIVATIVES, MEDICATIONS, CONTAINING SAID COMPOUNDS AND THEIR APPLICATION | 2003 |
|
RU2340622C2 |
